A number of recombinant drug products will be launched in the domestic market by the end of the current Iranian year (March 20, 2016), said Health Minister Hassan Ghazizadeh Hashemi. Such drugs are currently imported at high costs and “our specialists have been striving to produce them domestically,” he was quoted by IRNA as saying.
